Author:
Zhao Yinan,Nie Fan,Liu Wenhui,He Wenrui,Guo Yuanqiang
Funder
National Natural Science Foundation of China
Reference41 articles.
1. Chemical constituents and pharmacological properties of Poria cocos;Ríos;Planta Med.,2011
2. The inhibition of Mpro, the primary protease of COVID-19, by Poria cocos and its active compounds: a network pharmacology and molecular docking study;Wu;RSC Adv.,2021
3. Phytochemistry and pharmacological activities of Wolfiporia cocos (F.A. Wolf) Ryvarden & Gilb;Nie;Front. Pharmacol.,2020
4. Prospects of Poria cocos polysaccharides: isolation process, structural features and bioactivities;Jia;Trends Food Sci. Technol.,2016
5. Keishibukuryogan (gui-zhi-fu-ling-wan), a Kampo formula, decreases disease activity and soluble vascular adhesion molecule-1 in patients with rheumatoid arthritis;Nozaki;Evidence-based Complementary and Alternative Medicine: eCAM,2006